首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Gene therapy

缩写:GENE THER

ISSN:0969-7128

e-ISSN:1476-5462

IF/分区:4.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1997
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Séverine Périan,Eva Castellano,Caroline Costa et al. Séverine Périan et al.
Previously, we confirmed that BaEV-LVs outperformed VSV-G-LVs for gene delivery or correction of human T cells, B cells, NK cells and HSPCs correlating with high expression of its receptors, ASCT-1 and ASCT-2 on these cells. Since HERV-W gp...
Karthikeya S V Gottimukkala,Daniel D Lane,Rachel Cunningham et al. Karthikeya S V Gottimukkala et al.
Efficient delivery of CRISPR ribonucleoproteins into primary hematopoietic stem and progenitor cells (HSPCs) is essential for durable gene editing therapies but remains challenging. Here, we advance a modular, benchtop-assembled gold-polyme...
Maria Bunuales,Susana Inoges,Ascension Lopez-Diaz de Cerio et al. Maria Bunuales et al.
Adoptive Cell Therapies based on cytokine-induced killer cells (CIKs) can address the heterogeneity of solid tumors due to their multiple mechanisms of cancer cell recognition. However, tumor trafficking is one of the main limitations. In t...
Piia Käyhty,Tiina Nieminen,Reetta A E Eriksson et al. Piia Käyhty et al.
Immune responses against recombinant adeno-associated virus (rAAV) are one of the major obstacles in gene therapy. We investigated the potential of Programmed Death 1 ligands 1 and 2 (PD-L1/2) to protect AAV-transduced cells from immunologi...
Muhammad Shahrukh,Julianne R Sweeney,Tony Del Rio et al. Muhammad Shahrukh et al.
Adeno-associated virus (AAV)-based gene therapies have garnered significant attention and investment due to their clinical success and potential to address underlying causes of many diseases. AAV vectors provide effective delivery of therap...
Philipp Berg,Charlotte Bakker,Moritz Sander et al. Philipp Berg et al.
This article provides a regulatory perspective on secondary malignancy of T-cell origin as a rare adverse reaction to the currently marketed CD19- or BCMA-directed chimeric antigen receptor (CAR) T-cell therapies. To assess the risk, causal...
Victoria A C Palmgren,Miffy Hok Yan Cheng,Yao Zhang et al. Victoria A C Palmgren et al.
Retinitis pigmentosa (RP) associated with mutations in the rhodopsin gene (RHO) is a significant cause of blindness. Here we report on the application of adenine base editing of the c.1030C>T (p.Q344X) RHO mutation linked to RP. Using a flu...
Chinwendu Chukwu,Jinyun Yuan,Hong Chen Chinwendu Chukwu
Adeno-associated viruses (AAVs) hold significant promise for gene therapy targeting the central nervous system (CNS). However, current delivery methods are either invasive or cause significant systemic exposure. Intranasal (IN) delivery pre...
Selin Saydam,Pervin Dinçer Selin Saydam
Base Editing (BE) and Prime Editing (PE), novel precision tools of the CRISPR/Cas toolbox, have emerged as transformative technologies that enable highly specific genetic modifications. Their compatibility with post-mitotic cell types makes...
Mahmoud Fawzi Osman,Khalid Ibrahim,Claire Gleeson et al. Mahmoud Fawzi Osman et al.
Duchenne Muscular Dystrophy is a rare, X-linked neuromuscular disorder that leads to progressive muscle degeneration, loss of ambulation, and premature mortality due to respiratory and cardiac failure. Historically, Duchennke Muscular Dystr...